نتائج البحث - Kate Newbold

تنقيح النتائج
  1. 1
    Updates on the Management of Advanced, Metastatic, and Radioiodine Refractory Differentiated Thyroid Cancer

    Updates on the Management of Advanced, Metastatic, and Radioiodine Refractory Differentiated Thyroid Cancer حسب Dario Tumino, Francesco Frasca, Kate Newbold

    منشور في 2017
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Clinical evaluation of intensity-modulated radiotherapy for head and neck cancers

    Clinical evaluation of intensity-modulated radiotherapy for head and neck cancers حسب Shreerang Bhide, Kate Newbold, Kevin J. Harrington, Christopher M. Nutting

    منشور في 2012
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Recurrence after low-dose radioiodine ablation and recombinant human thyroid-stimulating hormone for differentiated thyroid cancer (HiLo): long-term results of an open-label, non-inferiority randomised controlled trial

    Recurrence after low-dose radioiodine ablation and recombinant human thyroid-stimulating hormone for differentiated thyroid cancer (HiLo): long-term results of an open-label, non-i... حسب Hakim‐Moulay Dehbi, Ujjal K. Mallick, Jonathan Wadsley, Kate Newbold, Clive Harmer, Allan Hackshaw

    منشور في 2018
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    2019 European Thyroid Association Guidelines for the Treatment and Follow-Up of Advanced Radioiodine-Refractory Thyroid Cancer

    2019 European Thyroid Association Guidelines for the Treatment and Follow-Up of Advanced Radioiodine-Refractory Thyroid Cancer حسب Laura Fugazzola, Rossella Elisei, Dagmar Führer, Barbara Jarząb, Sophie Leboulleux, Kate Newbold, Johannes W. A. Smit

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up حسب Sébastiano Filetti, Cosimo Durante, Dana M. Hartl, Sophie Leboulleux, Laura D. Locati, Kate Newbold, Mauro Papotti, Alfredo Berruti

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    ESMO Clinical Practice Guideline update on the use of systemic therapy in advanced thyroid cancer

    ESMO Clinical Practice Guideline update on the use of systemic therapy in advanced thyroid cancer حسب Sébastiano Filetti, Cosimo Durante, Dana M. Hartl, Sophie Leboulleux, Laura D. Locati, Kate Newbold, Mauro Papotti, Alfredo Berruti

    منشور في 2022
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Neurocognitive Function After (Chemo)-Radiotherapy for Head and Neck Cancer

    Neurocognitive Function After (Chemo)-Radiotherapy for Head and Neck Cancer حسب Liam Welsh, Alex Dunlop, T. McGovern, Dualta Mcquaid, Jamie Dean, S. Gulliford, Shree Bhide, Kevin J. Harrington, Chris Nutting, Kate Newbold

    منشور في 2014
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Taste dysfunction following radiotherapy to the head and neck: A systematic review

    Taste dysfunction following radiotherapy to the head and neck: A systematic review حسب Lucinda Gunn, James Gilbert, Pablo Nenclares, Heba Soliman, Kate Newbold, Shree Bhide, Kee H. Wong, Kevin J. Harrington, Chris Nutting

    منشور في 2021
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Management of Invasive Differentiated Thyroid Cancer

    Management of Invasive Differentiated Thyroid Cancer حسب Iain J. Nixon, Ricard Simó, Kate Newbold, Alessandra Rinaldo, Carlos Suárez, Luiz Paulo Kowalski, Carl Silver, Jatin P. Shah, Alfio Ferlito

    منشور في 2016
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Radiosensitization by the ATR Inhibitor AZD6738 through Generation of Acentric Micronuclei

    Radiosensitization by the ATR Inhibitor AZD6738 through Generation of Acentric Micronuclei حسب Magnus T. Dillon, Holly E. Barker, Malin Pedersen, Hind Hafsi, Shreerang Bhide, Kate Newbold, Christopher M. Nutting, Martin McLaughlin, Kevin J. Harrington

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    Vandetanib in Advanced Medullary Thyroid Cancer: Review of Adverse Event Management Strategies

    Vandetanib in Advanced Medullary Thyroid Cancer: Review of Adverse Event Management Strategies حسب Enrique Grande, Michael C. Kreißl, Sébastiano Filetti, Kate Newbold, Walter Reinisch, Caroline Robert, Martin Schlumberger, Lærke Kjær Tolstrup, José Luís Zamorano, Jaume Capdevila

    منشور في 2013
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    Normal tissue complication probability (NTCP) modelling using spatial dose metrics and machine learning methods for severe acute oral mucositis resulting from head and neck radiotherapy

    Normal tissue complication probability (NTCP) modelling using spatial dose metrics and machine learning methods for severe acute oral mucositis resulting from head and neck radioth... حسب Jamie Dean, Kee H. Wong, Liam Welsh, Ann-Britt Jones, Ulrike Schick, Kate Newbold, Shreerang Bhide, Kevin J. Harrington, Christopher M. Nutting, S. Gulliford

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    Paediatric differentiated thyroid carcinoma: a UK National Clinical Practice Consensus Guideline

    Paediatric differentiated thyroid carcinoma: a UK National Clinical Practice Consensus Guideline حسب Sasha Howard, Sarah Freeston, Barney Harrison, Louise Izatt, Sonali Natu, Kate Newbold, Sabine Pomplun, Helen Spoudeas, Sophie Wilne, Tom Kurzawinski, Mark N. Gaze

    منشور في 2022
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  14. 14
    Investigating the potential clinical benefit of Selumetinib in resensitising advanced iodine refractory differentiated thyroid cancer to radioiodine therapy (SEL-I-METRY): protocol for a multicentre UK single arm phase II trial

    Investigating the potential clinical benefit of Selumetinib in resensitising advanced iodine refractory differentiated thyroid cancer to radioiodine therapy (SEL-I-METRY): protocol... حسب Sarah Brown, Andrew Hall, Hannah Buckley, Louise Flanagan, David González de Castro, Kate Farnell, Laura Moss, Rebecca Gregory, Kate Newbold, Yong Du, Glenn Flux, Jonathan Wadsley

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  15. 15
    On-treatment immune prognostic score for patients with relapsed and/or metastatic head and neck squamous cell carcinoma treated with immunotherapy

    On-treatment immune prognostic score for patients with relapsed and/or metastatic head and neck squamous cell carcinoma treated with immunotherapy حسب Pablo Nenclares, Lucinda Gunn, Heba Soliman, Mateo Bover, Amy Trinh, Isla Leslie, Kee H. Wong, Alan Melcher, Kate Newbold, Chris Nutting, Derfel ap Dafydd, Shreerang Bhide, Kevin J. Harrington

    منشور في 2021
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  16. 16
    Treatment-emergent hypertension and efficacy in the phase 3 Study of (E7080) lenvatinib in differentiated cancer of the thyroid (SELECT)

    Treatment-emergent hypertension and efficacy in the phase 3 Study of (E7080) lenvatinib in differentiated cancer of the thyroid (SELECT) حسب Lori J. Wirth, Makoto Tahara, Bruce Robinson, Sanjeev Francis, Marcia S. Brose, Mouhammed Amir Habra, Kate Newbold, Naomi Kiyota, Corina E. Dutcus, Elton Mathias, Matthew Guo, Steven I. Sherman, Martin Schlumberger

    منشور في 2018
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  17. 17
    Phase I/II Study of Oncolytic HSVGM-CSF in Combination with Radiotherapy and Cisplatin in Untreated Stage III/IV Squamous Cell Cancer of the Head and Neck

    Phase I/II Study of Oncolytic HSVGM-CSF in Combination with Radiotherapy and Cisplatin in Untreated Stage III/IV Squamous Cell Cancer of the Head and Neck حسب Kevin J. Harrington, Mohan Hingorani, Mary Anne Tanay, Jennifer Hickey, Shreerang Bhide, Peter Clarke, Louise C. Renouf, Khin Thway, Amen Sibtain, Iain A. McNeish, Kate Newbold, Howard Goldsweig, Robert S. Coffin, Christopher M. Nutting

    منشور في 2010
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  18. 18
    The Predictive Value of Early Assessment After 1 Cycle of Induction Chemotherapy with <sup>18</sup>F-FDG PET/CT and Diffusion-Weighted MRI for Response to Radical Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma

    The Predictive Value of Early Assessment After 1 Cycle of Induction Chemotherapy with <sup>18</sup>F-FDG PET/CT and Diffusion-Weighted MRI for Response to Radical Chemoradiotherapy... حسب Kee H. Wong, Rafał Panek, Liam Welsh, Dualta Mcquaid, Alex Dunlop, Angela M. Riddell, Iain Murray, Yong Du, Sue Chua, Dow‐Mu Koh, Shreerang Bhide, Chris Nutting, Wim J.G. Oyen, Kevin J. Harrington, Kate Newbold

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  19. 19
    Changes in multimodality functional imaging parameters early during chemoradiation predict treatment response in patients with locally advanced head and neck cancer

    Changes in multimodality functional imaging parameters early during chemoradiation predict treatment response in patients with locally advanced head and neck cancer حسب Kee H. Wong, Rafał Panek, Alex Dunlop, Dualta Mcquaid, Angela M. Riddell, Liam Welsh, Iain Murray, Dow‐Mu Koh, Martin O. Leach, Shreerang Bhide, Christopher M. Nutting, Wim J.G. Oyen, Kevin J. Harrington, Kate Newbold

    منشور في 2017
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  20. 20
    DARS: a phase III randomised multicentre study of dysphagia- optimised intensity- modulated radiotherapy (Do-IMRT) versus standard intensity- modulated radiotherapy (S-IMRT) in head and neck cancer

    DARS: a phase III randomised multicentre study of dysphagia- optimised intensity- modulated radiotherapy (Do-IMRT) versus standard intensity- modulated radiotherapy (S-IMRT) in hea... حسب Imran Petkar, Keith Rooney, Justin Roe, Joanne Patterson, D. Bernstein, Justine Tyler, Marie A. Emson, James P. Morden, Kathrin Mertens, Elizabeth Miles, Matthew Beasley, Tom Roques, Shreerang Bhide, Kate Newbold, Kevin J. Harrington, Emma Hall, Christopher M. Nutting

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: